Identification of Novel DNA Methylation Prognostic Biomarkers for AML With Normal Cytogenetics
{{output}}
Purpose: AML is a hematologic cancer that is clinically heterogeneous, with a wide range of clinical outcomes. DNA methylation changes are a hallmark of AML but are not routinely used as a criterion for risk stratification. The a... ...
